nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadopentetate dimeglumine—PGD—uterine cervix—fallopian tube cancer	0.206	0.206	CbGeAlD
Gadopentetate dimeglumine—PGD—endometrium—fallopian tube cancer	0.187	0.187	CbGeAlD
Gadopentetate dimeglumine—PGD—uterus—fallopian tube cancer	0.172	0.172	CbGeAlD
Gadopentetate dimeglumine—PGD—female reproductive system—fallopian tube cancer	0.155	0.155	CbGeAlD
Gadopentetate dimeglumine—PGD—female gonad—fallopian tube cancer	0.141	0.141	CbGeAlD
Gadopentetate dimeglumine—PGD—vagina—fallopian tube cancer	0.14	0.14	CbGeAlD
